// App-Quantinova.ai

PB0475 : Acquired Antithrombin III Deficiency Is a Risk Factor for Venous Thromboembolism after Severe Injury

Researchers

Presenter

  • E. Rahbar

Principal Investigators

  • B. Cotton

  • C. Wade

  • J. Cardenas

Medical Centers

  • Wake Forest University, Biomedical Engineering, Winston Salem, United States

  • The University of Texas Health Science Center at Houston, Houston, United States of America

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Genetic Disorder

Disease

  • Antithrombin III deficiency

  • Venous thrombosis

Biomarkers

  • Antithrombin III

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved